WHX Labs in Dubai to gather global experts in Antimicrobial Resistance at inaugural AMR Leaders’ Summit
- The World Health Organisation (WHO) warns that AMR could add up to $1 trillion in global healthcare costs within the next 25 years
- The AMR Leaders’ Summit, held at WHX Labs in Dubai will bring together clinicians, policymakers and scientists to close the gap between research and implementation
- WHX Labs in Dubai will take place from 10-13 February at Dubai World Trade Centre
Dubai, United Arab Emirates, 7 January 2026: World Health Expo (WHX) Labs in Dubai (formerly Medlab Middle East), which will be held at Dubai World Trade Centre from 10-13 February, will address the growing global threat of antimicrobial resistance (AMR), predicted by the World Health Organisation (WHO) to cause up to 10 million deaths annually and a potential $1 trillion in additional healthcare costs worldwide by 2050.
AMR occurs when bacteria, viruses and fungi evolve to resist medications, making infections harder to treat and increasing the risk of severe illness, disability and death. The misuse and overuse of antimicrobials in humans, animals and agriculture remain the leading drivers of AMR, with systematic gaps accelerating the threat.
While investment for research and development (R&D) increased by 10% between 2017 and 2019, progress continues to be hindered by a limited pipeline of new drugs, especially when compared with funding for diagnostics.
A flagship launch for WHX Labs in Dubai 2026, the AMR Leaders’ Summit, held from 12-13 February, will spotlight AMR by bringing together scientists, clinicians, policymakers, and innovators to bridge the gap between research and implementation.
Chaired by Dr Wael Elamin, Medical Director, Environmental Sciences, M42, the co-chairs for the event are Prof. Abiola Senok, Chair of Basic Medical Sciences and Professor, Microbiology and Infectious Diseases, MBRU; Dr. Kavita Diddi, President, Emirates Society of Clinical Microbiology (ESCM)Ms; and Dr Seema Oommen, Section Head, Microbiology and Infectious Molecular, Burjeel Medical City.
Underscoring the importance of the summit, Dr Elamin said: “Antimicrobial resistance is no longer a future risk — it is a present and growing threat to global health security. Tackling AMR requires alignment across policy, diagnostics, clinical practice and innovation. The AMR Leaders’ Summit at WHX Labs in Dubai is designed to move beyond discussion and drive practical solutions that enhance surveillance, support responsible antimicrobial use and protect patient outcomes worldwide.”
The opening day of the AMR Leaders’ Summit will focus on the global and national response to AMR, with keynote insights from the WHO and regional public health leaders, alongside expert discussions on technology and innovation. Sessions will also explore genomics, equity in AMR policy and how hospital practices are expected to evolve by 2028.
Dr Souha Kanj, Professor of Medicine and Chair of the Infection Control and Prevention Program at the American University of Beirut (AUB), will deliver the opening keynote that day, addressing antimicrobial resistance in conflict zones.
Speaking ahead of the summit, she said: “Policy discussions focus on national action plans, regulatory frameworks, and governance structures, while acknowledging that many countries - particularly those affected by conflict or economic instability - struggle to fully implement global AMR recommendations. The summit addresses how policy can remain effective and flexible in fragile contexts, where traditional health system assumptions do not always apply.”
The second day of the AMR Leaders’ Summit will shift the focus to leadership, innovation and One Health approaches, highlighting lessons from Africa and the Middle East in areas such as genomic surveillance, epidemiology and the environmental determinants of AMR. Throughout the programme, open-mic sessions and networking opportunities will encourage dialogue between stakeholders, reinforcing the summit’s objective of moving beyond awareness toward coordinated, implementable actions that strengthen global AMR preparedness and healthcare resilience.
